Opens print. Choose "Save as PDF" and turn on background graphics. MedPrep
Stop injecting LA at the first symptoms. Call for help and get the 20% lipid emulsion early. Prolonged CPR may be needed; lipid is part of the resuscitation.

Early symptoms

  • Perioral tingling, tinnitus, metallic taste
  • Agitation, confusion, visual disturbance
  • Seizures without hypoglycaemia

Late symptoms

  • Arrhythmias, cardiovascular collapse
  • May resemble other causes: still give lipid if LAST likely
  • Maximum doses depend on agent, site, adrenaline use

Early CNS

  • Perioral tingling, tinnitus, metallic taste
  • Agitation, confusion
  • Stop injecting, call for help

Seizures

  • Seizures without hypoglycaemia
  • Treat with a benzodiazepine
  • Get 20% lipid emulsion now

Cardiovascular collapse

  • Arrhythmia or arrest
  • Lipid 1.5 mL/kg bolus then infusion
  • Prolonged ALS, avoid vasopressin

LAST response

1
1. Stop LA
Airway support, high-flow oxygen. Treat seizures with benzodiazepine; avoid propofol if unstable.
↓
2
2. Lipid emulsion
20% lipid: 1.5 mL/kg bolus over 1 min, then an infusion of 15 mL/kg/h. Repeat the bolus up to twice at 5-min intervals and double the infusion rate if the patient remains unstable (approximate maximum 12 mL/kg).
↓
3
3. CPR
Standard ALS if in arrest, but expect a prolonged resuscitation. Avoid vasopressin; use smaller adrenaline boluses and avoid calcium channel blockers and lidocaine (follow the LAST algorithm).
↓
4
4. Aftercare
ITU monitoring. Report to national audit. Review total LA dose and technique.

High-risk blocks

  • Interscalene, supraclavicular, penile block
  • Use ultrasound, aspirate, incremental doses

Pitfalls

  • Confusing LAST with anaphylaxis (try both pathways if unsure)
  • Under-dosing lipid
  • Continuing block after mild CNS symptoms

MedPrep - www.medprep.uk - Educational revision aid only. Not clinical guidance. Doses are adult examples; check the BNF, current guidelines and local policy, and seek senior advice. Nov 2026